These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 33373044)

  • 41. ABCD1 deletion-induced mitochondrial dysfunction is corrected by SAHA: implication for adrenoleukodystrophy.
    Baarine M; Beeson C; Singh A; Singh I
    J Neurochem; 2015 May; 133(3):380-96. PubMed ID: 25393703
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Phenotypic variability in a Tunisian family with X-linked adrenoleukodystrophy caused by the p.Gln316Pro novel mutation.
    Kallabi F; Ellouz E; Tabebi M; Ben Salah G; Kaabechi N; Keskes L; Triki C; Kamoun H
    Clin Chim Acta; 2016 Jan; 453():141-6. PubMed ID: 26686776
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Co-expression of mutated and normal adrenoleukodystrophy protein reduces protein function: implications for gene therapy of X-linked adrenoleukodystrophy.
    Unterrainer G; Molzer B; Forss-Petter S; Berger J
    Hum Mol Genet; 2000 Nov; 9(18):2609-16. PubMed ID: 11063720
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Altered expression of ALDP in X-linked adrenoleukodystrophy.
    Watkins PA; Gould SJ; Smith MA; Braiterman LT; Wei HM; Kok F; Moser AB; Moser HW; Smith KD
    Am J Hum Genet; 1995 Aug; 57(2):292-301. PubMed ID: 7668254
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Molecular characterization of X-linked adrenoleukodystrophy in a Tunisian family: identification of a novel missense mutation in the ABCD1 gene.
    Kallabi F; Hadj Salem I; Ben Salah G; Ben Turkia H; Ben Chehida A; Tebib N; Fakhfakh F; Kamoun H
    Neurodegener Dis; 2013; 12(4):207-11. PubMed ID: 23651979
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Easily misdiagnosed X-linked adrenoleukodystrophy.
    Wang QH; Wang YY; Wang J; Liu LY; Gao J; Hao GZ; Chen C; Lu Q; Dun S; Zhang Q; Zou LP
    Ital J Pediatr; 2024 Jul; 50(1):124. PubMed ID: 38956688
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Overview of X-linked adrenoleukodystrophy in Morocco: results of the implementation of the program of clinical and biological diagnosis].
    Benjelloun FM; Chabraoui L; Kriouile Y
    Pan Afr Med J; 2017; 28():185. PubMed ID: 29599883
    [TBL] [Abstract][Full Text] [Related]  

  • 48. X-linked adrenoleukodystrophy: clinical, metabolic, genetic and pathophysiological aspects.
    Kemp S; Berger J; Aubourg P
    Biochim Biophys Acta; 2012 Sep; 1822(9):1465-74. PubMed ID: 22483867
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Adrenoleukodystrophy: structure and function of ALDP, and intracellular behavior of mutant ALDP with naturally occurring missense mutations].
    Takahashi N; Morita M; Imanaka T
    Yakugaku Zasshi; 2007 Jan; 127(1):163-72. PubMed ID: 17202797
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A Distinct Clinical Phenotype in Two Siblings with X-linked Adrenoleukodystrophy.
    Ozdemir Kutbay N; Ozbek MN; Sarer Yurekli B; Demirbilek H
    Neuro Endocrinol Lett; 2019 Mar; 40(1):36-40. PubMed ID: 31184821
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Profiling and Imaging of Phospholipids in Brains of Abcd1-Deficient Mice.
    Hama K; Fujiwara Y; Morita M; Yamazaki F; Nakashima Y; Takei S; Takashima S; Setou M; Shimozawa N; Imanaka T; Yokoyama K
    Lipids; 2018 Jan; 53(1):85-102. PubMed ID: 29469952
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A very long-chain acyl-CoA synthetase-deficient mouse and its relevance to X-linked adrenoleukodystrophy.
    Heinzer AK; Watkins PA; Lu JF; Kemp S; Moser AB; Li YY; Mihalik S; Powers JM; Smith KD
    Hum Mol Genet; 2003 May; 12(10):1145-54. PubMed ID: 12719378
    [TBL] [Abstract][Full Text] [Related]  

  • 53. X-linked adrenoleukodystrophy in a chimpanzee due to an ABCD1 mutation reported in multiple unrelated humans.
    Curiel J; Steinberg SJ; Bright S; Snowden A; Moser AB; Eichler F; Dubbs HA; Hacia JG; Ely JJ; Bezner J; Gean A; Vanderver A
    Mol Genet Metab; 2017 Nov; 122(3):130-133. PubMed ID: 28919002
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Generation of two human induced pluripotent stem cell lines derived from two X-linked adrenoleukodystrophy patients with ABCD1 mutations.
    Kuramochi Y; Awaya T; Matsuo-Takasaki M; Takami M; An Y; Li J; Hemmi Y; Wakabayashi T; Arai Y; Inoue J; Noguchi M; Nakamura Y; Asaka I; Akimoto K; Saito MK; Hayashi Y
    Stem Cell Res; 2021 May; 53():102337. PubMed ID: 33901816
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cerebral inflammation in X-linked adrenoleukodystrophy.
    McGuinness MC; Smith KD
    Arch Immunol Ther Exp (Warsz); 1999; 47(5):281-7. PubMed ID: 10604233
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In vivo gene editing via homology-independent targeted integration for adrenoleukodystrophy treatment.
    Hong SA; Seo JH; Wi S; Jung ES; Yu J; Hwang GH; Yu JH; Baek A; Park S; Bae S; Cho SR
    Mol Ther; 2022 Jan; 30(1):119-129. PubMed ID: 34058389
    [TBL] [Abstract][Full Text] [Related]  

  • 57. X-linked adrenoleukodystrophy in women: a cross-sectional cohort study.
    Engelen M; Barbier M; Dijkstra IM; Schür R; de Bie RM; Verhamme C; Dijkgraaf MG; Aubourg PA; Wanders RJ; van Geel BM; de Visser M; Poll-The BT; Kemp S
    Brain; 2014 Mar; 137(Pt 3):693-706. PubMed ID: 24480483
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Adrenoleukodystrophy and adrenomyeloneuropathy. Clinical biochemical and molecular genetic findings].
    Vorgerd M; Benkmann HG; Tegenthoff M; Gal A; Malin JP
    Nervenarzt; 1998 Feb; 69(2):174-9. PubMed ID: 9551465
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Epigenomic signature of adrenoleukodystrophy predicts compromised oligodendrocyte differentiation.
    Schlüter A; Sandoval J; Fourcade S; Díaz-Lagares A; Ruiz M; Casaccia P; Esteller M; Pujol A
    Brain Pathol; 2018 Nov; 28(6):902-919. PubMed ID: 29476661
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pathogenicity of novel ABCD1 variants: The need for biochemical testing in the era of advanced genetics.
    Schackmann MJ; Ofman R; van Geel BM; Dijkstra IM; van Engelen K; Wanders RJ; Engelen M; Kemp S
    Mol Genet Metab; 2016 Jun; 118(2):123-7. PubMed ID: 27067449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.